Fluticasone Propionate (XHANCE) Receives FDA Approval for Chronic Rhinosinusitis
HCPLive
MARCH 15, 2024
On March 15, 2024, the FDA approval of fluticasone propionate nasal spray marks the first approval in agency history for treatment of chronic rhinosinusitis without nasal polyps.
Let's personalize your content